News

Latest news
October 17, 2026

20 scientific presentations underscore the breadth of AbbVie's leadership in Inflammatory Bowel Disease (IBD) research programs Latest long-term and real-world data with SKYRIZI®(risankizumab)...

October 13, 2026

Higher rates of endoscopic remission and ulcer-free endoscopy were observed following subcutaneous SKYRIZI® (risankizumab-rzaa)treatment versus placeboi Results build on previously reported week...

October 11, 2026

New Phase 3 AFFIRM data show higher rates of clinical and endoscopic response in Crohn's disease patients treated with subcutaneous SKYRIZI versus placebo across all efficacy endpoints and...

More »

AbbVie on

Looking for more news from AbbVie? Follow us on social media.

Advanced Search
  • April 28, 2016
    We believe 2016 is off to an exceptional start, with double-digit sales and adjusted earnings growth in the first quarter. Read the full news release.
  • April 11, 2016
    World Parkinson’s Day is observed annually on April 11 to raise awareness of the disease, promoting a greater understanding of the condition and how it can affect a person. Learn more about the disease, how many people are impacted, treatment and more.
  • April 06, 2016
    Today, students with cystic fibrosis (CF) are living longer and conquering high school, college and even graduate school. AbbVie is proud to assist them through our CF Scholarship program.
  • April 04, 2016
    The AbbVie Foundation recently launched a new website to shine a light on the needs of the underserved around the world and highlight the high-impact work the Foundation supports through its partners.
  • January 29, 2016
    A strong 2015 saw our revenue grow 15 percent, delivering adjusted earnings-per-share of $4.29, up 29 percent from a year ago, and generating momentum we expect to build upon in 2016.
Show 5102550100 per page
Who we are

Get to know the passionate people who make up AbbVie and the difference we strive to make, one patient at a time. Learn more

Sustainability

Our commitment to science is a commitment to better our society. Read our 2025 ESG report

Key Facts

Get a closer look at our impact. 
Learn more

Annual report

See our latest 2025 Annual Report on Form 10-K. Learn more

YOU ARE ABOUT TO LEAVE FOR A 3RD PARTY WEBSITE

Notice

The "Yes" link below will take you out of the AbbVie family of websites.

Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to leave this site?